Phamacovigilance Asia 2011 October 17, 2011

Pharmacovigilance Asia provides a platform connecting regulatory authorities, and industry professionals to brainstorm and share insights on Drug life cycle risk management; Realizing regulatory standardization and harmonization in Asia; Systems compatibility for streamlined safety data management; Training and building your pharmacovigilance team; and
Engaging healthcare professionals and consumers for effective drug safety communication.
Highlights of the conference this year include Full day regulatory updates from ten countries; Speakers presenting on the latest regulatory development and risk management plan from European Commission, Japan, Australia and China; 2 hands-on workshops on developing risk management plans, and increase pharmacovigilance team productivity through the automated systems.
2011 Confirmed Speakers include Patrick Deboyser, Advisor in the Directorate General for Health and Consumers, European Commission; Doris Stenver, Chief Medical Officer, Consumer Safety Division, Danish Medicines Agency; Member of European; Pharmacovigilance Working Party;
Shirley Ramesh, Senior Officer, Standards and Conformance Unit, Trade and Facilitation Division, Market Integration Directorate, ASEAN Secretariat; Philippe Van de Auwera, Global Head of Safety Risk Management and EU-QPPV, Roche;
Jean-Christophe Delumeau, Head of Pharmacovigilance Asia-Pacific, Bayer Healthcare Global R&D Center; Danny Hodder, Regional Director Asia Pacific, Global Security, AstraZeneca; Joy Li, Director, Pharmacovigilance and Medical Governance Development, GlaxoSmithKline; and Jean-Christophe Delumeau, Head of Pharmacovigilance, Asia-Pacific Bayer Healthcare Global R&D Centre.

Official Website: http://www.pharmacovigilanceasia.com